Cite Filings / CMPX / 0000947871-22-001162

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Compass Therapeutics, Inc. Filed 2022-11-10 Acc 0000947871-22-001162

Documents 1

SC 13D/A Beneficial Ownership Report , ss1505016_sc13da.htm

Around this filing

2024-03-22 SC 13D/A Beneficial Ownership Report
2022-11-10 4 Director bought 402,000 shares at $3.21 ($1,290,420)
2022-11-10 4 Director bought 402,000 shares at $3.21 ($1,290,420)
2022-11-10 SC 13D/A Beneficial Ownership Report
2022-11-10 3 Initial Statement of Ownership
2022-11-09 10-Q Quarterly Report
2021-11-09 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ss1505016_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…